FindTrial
Sign In

Network Meta-analysis of Partial Nephrectomy and Ablative Therapies for Renal Tumor <=3 cm

Network Meta-analysis of Partial Nephrectomy and Ablative Therapies for Renal Tumor <=3 cm - Network Meta-analysis of Partial Nephrectomy and Ablative Therapies for Renal Tumor <=3 cm

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000059587
Enrollment
Unknown
Registered
2025-10-30
Start date
2025-10-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal tumor

Interventions

None listed

Sponsors

Yokohama City University Diagnostic Radiology Shingo Koyama
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Studies including patients with cT1a or cT1b renal tumors. Studies comparing partial nephrectomy and/or ablative therapies (radiofrequency ablation, cryoablation, or microwave ablation). Studies reporting outcomes related to recurrence, survival, complication rate, or renal function.

Exclusion criteria

Exclusion criteria: Case reports, review articles, letters, meta-analyses. Studies with no available outcome data. Non-human studies. Subgroup or secondary analyses. Duplicate or overlapping patient cohorts. Studies published in languages other than English.

Design outcomes

Primary

MeasureTime frame
local recurrence risk, all-cause mortality, cancer-specific mortality, complication rate—

Countries

Japan

Contacts

Public ContactShingo Koyama

Yokohama City University Hospital Diagnostic Radiology

singo109@yokohama-cu.ac.jp+8145-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026